No area of medicine has been the subject of more hype, misinformation, and confusion than developing web sites for physician practices. Hundreds and perhaps thousands of our urologic colleagues have created web sites only to be left with a bad taste about the time, money, and effort spent on a medium that does not appear to generate more patients or improve practice efficiency.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.